Teleflex acquires Essential Medical


Teleflex Incorporated has announced that it has acquired Essential Medical, a privately-held medical device company that has developed and commercialised the CE Marked Manta vascular closure device specifically designed for closure of large bore arteriotomies following procedures utilising devices or sheaths ranging in size from 10F to 18F (with maximum outer diameters up to 25F). In its CE Mark study, the Manta device demonstrated rapid and reliable haemostasis with its resorbable collagen-based technology and complication rates that were non-inferior to surgical and suture-based closure methods.

“We are very excited to announce this acquisition, which expands our presence in the structural heart and endovascular aneurysm repair markets,” says Liam Kelly, president and chief executive officer of Teleflex. Kelly adds, “The Manta vascular closure device represents a truly innovative solution to address closure-related complications and high costs associated with many large and rapidly growing interventional procedure categories, such as transcatheter aortic valve replacement, endovascular aneurysm repair and ventricular assist device implantation. Physician adoption of the Manta device in international markets has been impressive, with over 8,100 procedures completed to date across a number of countries in the EU. We believe we can leverage our strong presence in the interventional cardiology market to accelerate adoption and growth of this breakthrough technology worldwide. Following the anticipated FDA premarket approval of the vascular closure device in 2019, we expect the acquisition will be modestly accretive to our constant currency revenue growth and gross margins over a multi-year period.”

“The combination of Teleflex and Essential Medical provides an excellent opportunity to maximize physician and patient access to the Manta vascular closure device ,” states Greg Walters, Essential Medical’s co-founder, president and CEO. “We are delighted to become an important part of Teleflex’s interventional cardiology business.”

The Manta  device is not approved for sale or distribution in the United States.


Please enter your comment!
Please enter your name here